Yayınlar & Eserler

Yayın Ağı
Makaleler 32
Tümü (32)
SCI-E, SSCI, AHCI (25)
SCI-E, SSCI, AHCI, ESCI (30)
ESCI (4)
Scopus (23)
TRDizin (4)
Diğer Yayınlar (1)

1. Development of Film Formulations of Acyclovir as Safe and Effective Antiviral Agent: Optimization, In Vitro Characterization and Antialphaherpesviral Efficacy

Ürgüplü B., Örgül D., VARAN G., Fedai T., Öztop S., ÖZKUL A., et al.
Journal of Pharmaceutical Innovation , cilt.21, sa.4, 2026 (SCI-Expanded, Scopus)

2. CD44-targeted cyclodextrin-hyaluronic acid nanoparticles carrying gemcitabine and paclitaxel to pancreatic cancer

VARAN G., Demirtürk N., Gökşen S., Benito J. M., Malanga M., ÖZTÜRK S. C., et al.
European Journal of Pharmaceutical Sciences , cilt.221, 2026 (SCI-Expanded, Scopus)

3. A PROMISING LIPOSOMAL VACCINE CANDIDATE AGAINST EPSTEIN-BARR VIRUS: AN IN VITRO EVALUATION EPSTEIN-BARR VİRÜSÜNE KARŞI UMUT VADEDEN LİPOZOMAL AŞI ADAYI: İN VİTRO DEĞERLENDİRME

Rezvankhah A., Secerli J., Güdül Bacanli M., VARAN G.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.50, sa.2, ss.322-337, 2026 (Scopus, TRDizin)

4. Screening Oil Components for Interleukin-2-Loaded Lipid-Based Formulations with Molecular Dynamics, In Vitro Characterization, and Cell Culture Evaluation

OLĞAÇ S., OLĞAÇ A., VARAN G., TEKSİN Z. Ş.
ACS Omega , cilt.11, sa.9, ss.15028-15043, 2026 (SCI-Expanded, Scopus)

5. Paclitaxel loaded human serum albumin nanoparticles, from batch to microfluidics: A smart manufacturing approach for nab-paclitaxel nanosimilar candidate and in vitro head-to-head comparison

Cobanoglu E., VARAN C., VARAN G., BİLENSOY E.
Journal of Drug Delivery Science and Technology , cilt.115, 2026 (SCI-Expanded, Scopus)

6. DENGUE VIRUS: EPIDEMIOLOGY, BIOLOGY AND CHALLENGES OF VACCINE DEVELOPMENT

Türegün Atasoy B., AYDIN S., VARAN G., DURUSU TANRIÖVER M.
journal of one health research , cilt.3, sa.1, ss.1-11, 2025 (Hakemli Dergi)

7. Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma

Demirturk N., VARAN G., KAĞA S., Malanga M., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.662, 2024 (SCI-Expanded, Scopus)

8. Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles' Biodistribution in Cancer

Goksen S., Varan G., Bilensoy E., Esendagli G.
MOLECULAR PHARMACEUTICS , cilt.21, sa.9, ss.4688-4699, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Influenza/B Yamagata Strain and Influenza Vaccines

SOYDAM S., VARAN G., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.29, sa.2, ss.165-171, 2024 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

10. In vitro and ex vivo evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma

Eke Z., Orgul D., VARAN G., ERDOĞDU N.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.50, sa.7, ss.593-604, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Cyclodextrin in Vaccines: Enhancing Efficacy and Stability

VARAN G.
FUTURE PHARMACOLOGY , sa.3, ss.597-611, 2023 (ESCI) Creative Commons License

12. Three-Dimensional Cell Culture Methods in Infectious Diseases and Vaccine Research

Varan G., Unal S.
Future Pharmacology , cilt.3, sa.1, ss.48-60, 2023 (Hakemli Dergi) Sürdürülebilir Kalkınma

13. Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors

ÜNAL S., VARAN G., Benito J. M., AKTAŞ Y., BİLENSOY E.
Beilstein Journal of Organic Chemistry , cilt.19, ss.139-157, 2023 (SCI-Expanded, Scopus) Creative Commons License

14. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer

Akkın S., Varan G., Işık A., Gökşen S., Karakoç E., Malanga M., et al.
PHARMACEUTICS , cilt.15, sa.2, ss.1-23, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU

Akkin S., VARAN G., AKSÜT D., Malanga M., ERCAN A., ŞEN M., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.623, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Peptide Based Vaccine Strategies

AYDIN S., VARAN G., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.27, sa.2, ss.189-195, 2022 (ESCI, TRDizin) Creative Commons License

17. COVID-19 Vaccine Development Studies and Nanotechnology Approaches

VARAN G., AYDIN DİLSİZ S., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , sa.4, ss.519-526, 2022 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

18. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers

Akkin S., VARAN G., BİLENSOY E.
MOLECULES , cilt.26, sa.11, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

19. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level

ERCAN A., ÇELEBİER M., ÖNCÜL S., VARAN G., KOÇAK E., Benito J. M., et al.
International Journal of Pharmaceutics , cilt.598, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

20. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver

Varan G., Demirturk N., Benito J. M., BİLENSOY E.
Journal of Drug Targeting , cilt.29, sa.4, ss.439-453, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

21. Therapeutic efficacy and biodistribution of paclitaxel-bound amphiphilic cyclodextrin nanoparticles: Analyses in 3D tumor culture and tumor-bearing animals in vivo

Varan G., Varan C., Öztürk S. C., Benito J. M., Esendağlı G., Bilensoy E.
Nanomaterials , cilt.11, sa.2, ss.1-18, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

22. Erlotinib complexation with randomly methylated beta-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

Erdogar N., Akkin S., VARAN G., BİLENSOY E.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.26, ss.797-806, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Cyclodextrin-Based Nanosystems: Current Status and Future Prospects

VARAN C., Varan G., Erdogar N., BİLENSOY E.
DRUG DELIVERY NANOSYSTEMS: FROM BIOINSPIRATION AND BIOMIMETICS TO CLINICAL APPLICATIONS , ss.29-58, 2019 (SCI-Expanded)

24. Plant-Based Natural Polymeric Nanoparticles as Promising Carriers for Anticancer Therapeutics

Varan G., VARAN C., BİLENSOY E.
POLYMERIC NANOPARTICLES AS A PROMISING TOOL FOR ANTI-CANCER THERAPEUTICS , ss.293-318, 2019 (SCI-Expanded)

25. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.
European Journal of Pharmaceutical Sciences , cilt.123, ss.377-386, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model

Varan G., Patrulea V., Borchard G., BİLENSOY E.
Nanomaterials , cilt.8, sa.2, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

27. Cyclodextrin-based polymeric nanosystems

Erdogar N., Varan G., VARAN C., BİLENSOY E.
DRUG TARGETING AND STIMULI SENSITIVE DRUG DELIVERY SYSTEMS , ss.715-748, 2018 (SCI-Expanded)

28. Amphiphilic cyclodextrin nanoparticles

VARAN G., VARAN C., ERDOĞAR N., Hincal A. A., BİLENSOY E.
International Journal of Pharmaceutics , cilt.531, sa.2, ss.457-469, 2017 (SCI-Expanded, Scopus)

29. Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors

ERDOĞAR N., VARAN G., BİLENSOY E.
Current Topics in Medicinal Chemistry , cilt.17, sa.13, ss.1521-1528, 2017 (SCI-Expanded, Scopus)

30. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

Varan G., Benito J. M., Mellet C. O., BİLENSOY E.
Beilstein Journal of Nanotechnology , cilt.8, sa.1, ss.1457-1468, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

31. Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles

VARAN G., ÖNCÜL S., ERCAN A., BENITO J. M., MELLET C. O., BİLENSOY E.
Journal of Pharmaceutical Sciences , cilt.105, sa.10, ss.3172-3182, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Cationic polymer nanoparticles for drug and gene delivery

BİLENSOY E., Işik G., VARAN C.
RSC Polymer Chemistry Series , sa.13, ss.268-295, 2015 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. Escherichia coli Kaynaklı Dış Zar Veziküllerinin İzolasyon Yöntemlerinin Karşılaştırılması

ARAL D., TÜREGÜN ATASOY B., VARAN G.
Tüm Paydaşlarıyla Aşı ve İmmünizasyon Kongresi 2025, 29 Kasım - 02 Aralık 2025, (Tam Metin Bildiri) Creative Commons License Sürdürülebilir Kalkınma

2. Limitations of BCG and Booster Vaccine Research

AYDIN S., VARAN G., TÜREGÜN ATASOY B., ÜNAL S.
2nd Edition of the Infectious Diseases World Conference World Vaccines R&D Conference, Paris, Fransa, 17 - 19 Ekim 2025, (Özet Bildiri)

3. Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer

ERDOĞDU N., Akkın S., VARAN G., BİLENSOY E.
13th Internation symposium of Pharmaceutical Science, Ankara, Türkiye, 22 - 25 Haziran 2021, (Tam Metin Bildiri)

4. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.
EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 Mart 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

5. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.
12 th International symposium on pharmaceutical sciences, 26 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

6. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 Mayıs 2018, (Tam Metin Bildiri)

7. Evaluation of Cholesterol-Targeted Amphiphilic Cyclodextrin Nanoparticles for Cancer Therapy

VARAN G., ÖNCÜL S., ERCAN A., BENİTO J., MELLET C. O., BİLENSOY E.
Innovation in Medicine Meetings III Congress, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma
Kitaplar 5

1. Folate receptor-mediated targeted breast cancer nanomedicine

Varan G., Varan C., Erdoğdu N., Bilensoy E.
Targeted Nanomedicine for Breast Cancer Therapy, Shivani Rai Paliwal,Rishi Paliwal, Editör, Academic Press , London, ss.153-169, 2022 Sürdürülebilir Kalkınma

2. Biodistribution of polymeric, polysaccharide and metallic nanoparticles

Erdoğdu N., Varan G., Varan C., Bilensoy E.
Characterization of Pharmaceutical Nano- and Microsystems, Peltonen Leena,Douroumis Dennis,Fahr Alfred,Siepmann Jurgen,Snowden Martin J., Editör, John Wiley & Sons, West Sussex, UK , Cambridge, ss.275-290, 2020

3. Cyclodextrin Based Nano-Systems: Current Status and Future Prospects

VARAN C., VARAN G., ERDOĞAR N., BİLENSOY E.
Drug Delivery Nanosystems: From Bioinspiration and Biomimetics to Clinical Applications, Pippa Natassa, Demetzos Costas, Pispas Stergios, Editör, Pan Stanford, ss.29-49, 2019

4. Plant based natural polymer (Guar gum, pectin, starch, cellulose, cyclodextrins) nanoparticles as promising tool for anticancer therapeutics

VARAN G., VARAN C., BİLENSOY E.
Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics, Prashant Kesharwani, Kishore M. Paknikar, Virendra Gajbhiye, Editör, Academic Press, 2019 Sürdürülebilir Kalkınma

5. Cyclodextrin-based polymeric nanosystems

ERDOĞAR N., VARAN G., VARAN C., BİLENSOY E.
Drug Targeting and Stimuli Sensitive Drug Delivery Systems, Alina M. Holban, Editör, William Andrew, ss.715-748, 2018
Metrikler

Yayın

45

Yayın (WoS)

30

Yayın (Scopus)

23

Atıf (WoS)

236

H-İndeks (WoS)

8

Atıf (Scopus)

514

H-İndeks (Scopus)

11

Atıf (Scholar)

18

H-İndeks (Scholar)

2

Proje

23

Tez Danışmanlığı

1

Açık Erişim

12
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 9: AMAÇ 9: SANAYİ, YENİLİKÇİLİK VE ALTYAPI
SDG 16: AMAÇ 16: BARIŞ VE ADALET